Page 80 - AN-3-1

Advanced Neurology COVID-19 and neurodegenerative diseases

2020;229(3):e13473. Raven; 1999.
doi: 10.1111/apha.13473 28. Beauchamp LC, Finkelstein DI, Bush AI, Evans AH,
Barnham KJ. Parkinsonism as a third wave of the COVID-19
17. Boldrini M, Canoll PD, Klein RS. How COVID-19 affects
the brain. JAMA Psychiatry. 2021;78(6):682-683. pandemic? J Parkinsons Dis. 2020;10(4):1343-1353.
doi: 10.3233/JPD-202211
doi: 10.1001/jamapsychiatry.2021.0500
29. Sulzer D, Antonini A, Leta V, et al. COVID-19 and possible
18. Mingoti MED, Bertollo AG, Simões JLB, Francisco GR,
Bagatini MD, Ignácio ZM. COVID-19, oxidative stress, and links with Parkinson’s disease and parkinsonism: From
neuroinflammation in the depression route. J Mol Neurosci. bench to bedside. NPJ Parkinsons Dis. 2020;6(1):18.
2022;72(6):1166-1181. doi: 10.1038/s41531-020-00123-0
doi: 10.1007/S12031-022-02004-Y 30. Beauchamp LC, Dore V, Villemagne VL, et al. Using
18F-AV-133 VMAT PET imaging to monitor progressive
19. Bowen DR, Pathak S, Nadar RM, et al. Oxidative stress and 2
COVID-19-associated neuronal dysfunction: Mechanisms nigrostriatal degeneration in Parkinson disease. Neurology.
and therapeutic implications. Acta Biochim Biophys Sin 2023;101(22):E2314-e2324.
(Shanghai). 2023;55(8):1153-1167. doi: 10.1212/WNL.0000000000207748
doi: 10.3724/ABBS.2023085 31. Del Prete E, Francesconi A, Palermo G, et al. Prevalence
and impact of COVID-19 in Parkinson’s disease: Evidence
20. Roldán-Santiago E, Benito-Berlinches A, Martínez-García L,
et al. Severe acute respiratory syndrome coronavirus 2 from a multi-center survey in Tuscany region. J Neurol.
spreads to lymph nodes and strongly expands CD4+ effector 2021;268(4):1179-1187.
memory RA cells in a patient with mild coronavirus disease doi: 10.1007/S00415-020-10002-6
2019. Clin Infect Dis. 2021;73(11):e3970-e3973.
32. Fasano A, Cereda E, Barichella M, et al. COVID-19 in
doi: 10.1093/CID/CIAA1422 Parkinson’s disease patients living in lombardy, Italy. Mov
Disord. 2020;35(7):1089-1093.
21. Rogers JP, Chesney E, Oliver D, et al. Psychiatric and
neuropsychiatric presentations associated with severe doi: 10.1002/MDS.28176
coronavirus infections: A systematic review and meta- 33. Cilia R, Bonvegna S, Straccia G, et al. Effects of COVID-19
analysis with comparison to the COVID-19 pandemic. on Parkinson’s disease clinical features: A community-based
Lancet Psychiatry. 2020;7(7):611-627.
case-control study. Mov Disord. 2020;35(8):1287-1292.
doi: 10.1016/S2215-0366(20)30203-0
doi: 10.1002/MDS.28170
22. Schrag A, Taddei RN. Depression and anxiety in Parkinson’s 34. Leta V, Rodríguez-Violante M, Abundes A, et al. Parkinson’s
disease. Int Rev Neurobiol. 2017;133:623-655.
disease and post-COVID-19 syndrome: The Parkinson’s
doi: 10.1016/BS.IRN.2017.05.024 long-COVID spectrum. Mov Disord. 2021;36(6):1287-1289.
23. Salari M, Zali A, Ashrafi F, et al. Incidence of anxiety doi: 10.1002/MDS.28622
in Parkinson’s disease during the coronavirus disease 35. Fasano A, Elia AE, Dallocchio C, et al. Predictors of
(COVID-19) pandemic. Mov Disord. 2020;35(7):1095-1096.
COVID-19 outcome in Parkinson’s disease. Parkinsonism
doi: 10.1002/MDS.28116 Relat Disord. 2020;78:134-137.
24. Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T. The doi: 10.1016/J.PARKRELDIS.2020.08.012
incidence of Parkinson’s disease: A systematic review and 36. Antonini A, Leta V, Teo J, Chaudhuri KR. Outcome of
meta-analysis. Neuroepidemiology. 2016;46(4):292-300.
Parkinson’s disease patients affected by COVID‐19. Mov
doi: 10.1159/000445751 Disord. 2020;35(6):905-908.
25. Ascherio A, Schwarzschild MA. The epidemiology of doi: 10.1002/MDS.28104
Parkinson’s disease: Risk factors and prevention. Lancet 37. Brown EG, Chahine LM, Goldman SM, et al. The effect
Neurol. 2016;15(12):1257-1272.
of the COVID-19 pandemic on people with Parkinson’s
doi: 10.1016/S1474-4422(16)30230-7 disease. J Parkinsons Dis. 2020;10(4):1365-1377.
26. Kim CY, Alcalay RN. Genetic forms of Parkinson’s disease. doi: 10.3233/JPD-202249
Semin Neurol. 2017;37(2):135-146.
38. Zhang Q, Schultz JL, Aldridge GM, Simmering JE,
doi: 10.1055/S-0037-1601567 Narayanan NS. Coronavirus disease 2019 case fatality and
Parkinson’s disease. Mov Disord. 2020;35(11):1914-1915.
27. Sian J, Youdim MBH, Riederer P, Gerlach M. MPTP-induced
Parkinsonian Syndrome. Philadelphia, PA: Lippincott- doi: 10.1002/MDS.28325

Volume 3 Issue 1 (2024) 9 https://doi.org/10.36922/an.2200